Artal Group’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-253,000
| Closed | -$10.6M | – | 116 |
|
|
2024
Q1 | $10.6M | Buy |
+253,000
| New | +$10.6M | 0.27% | 41 |
|
|
2021
Q1 | – | Sell |
-400,000
| Closed | -$7.01M | – | 145 |
|
|
2020
Q4 | $7.01M | Buy |
+400,000
| New | +$7.01M | 0.15% | 91 |
|
|
2018
Q1 | – | Sell |
-23,356
| Closed | -$995K | – | 93 |
|
|
2017
Q4 | $995K | Sell |
23,356
-21,644
| -48% | -$922K | 0.02% | 78 |
|
|
2017
Q3 | $1.93M | Hold |
45,000
| – | – | 0.03% | 63 |
|
|
2017
Q2 | $1.67M | Hold |
45,000
| – | – | 0.03% | 71 |
|
|
2017
Q1 | $2.44M | Hold |
45,000
| – | – | 0.05% | 59 |
|
|
2016
Q4 | $2.39M | Hold |
45,000
| – | – | 0.05% | 46 |
|
|
2016
Q3 | $2.73M | Hold |
45,000
| – | – | 0.05% | 52 |
|
|
2016
Q2 | $2.96M | Hold |
45,000
| – | – | 0.06% | 38 |
|
|
2016
Q1 | $2.55M | Buy |
45,000
+20,000
| +80% | +$1.13M | 0.05% | 34 |
|
|
2015
Q4 | $5.88M | Hold |
25,000
| – | – | 0.11% | 32 |
|
|
2015
Q3 | $3.95M | Buy |
25,000
+8,333
| +50% | +$1.32M | 0.09% | 26 |
|
|
2015
Q2 | $6.31M | Buy |
+16,667
| New | +$6.31M | 0.27% | 29 |
|